Peripheral nerve perfusion by dynamic contrast-enhanced magnetic resonance imaging: demonstration of feasibility.

PURPOSE

The aim of this study was to establish dynamic contrast-enhanced perfusion in peripheral nerves for determination of blood-nerve permeability (K) and nerve blood volume (NBV) in peripheral neuropathies as compared with healthy controls.

METHODS

The study was approved by the institutional ethics committee, and written informed consent was obtained from all participants. Forty-three controls (24 women, 19 men; age, 48.7 ± 17.5 years) and 59 patients with peripheral neuropathy (28 women, 31 men; age, 52.7 ± 12.4 years) were examined by a standard protocol including a T1-weighted dynamic contrast-enhanced sequence (time of repetition/time of echo, 4.91/1.64; 10 slices; resolution 0.8 × 0.6 × 3.0 mm3). Time - signal intensity analysis was performed by normalizing to pre-bolus arrival and calculating the mean contrast uptake (MCU) for each patient. Further analyses were performed by customized software to calculate K trans and NBV. Statistical analysis included 2-sided Student's t tests of controls versus patients, receiver operating characteristic analysis, and subgroup analysis of patients according to etiologies of neuropathy.

RESULTS

Time-signal intensity analysis showed significantly increased contrast uptake in patients as compared with controls (MCU, 1.29 ± 0.15 vs 1.18 ± 0.08; P < 0.001). This was caused mainly by an increase in K trans (0.046 ± 0.025 vs 0.026 ± 0.016 min(-1); P < 0.001) and less by an increase in NBV (3.9 ± 2.6 vs 3.0 ± 1.9 mL/100 mL; P = 0.12). This trend was true for all etiologies except entrapment neuropathies. Excluding these, receiver operating characteristic analysis found an area under the curve of 0.78 (95% confidence interval, 0.69-0.89) for MCU and 0.77 (95% confidence interval, 0.65-0.90) for K to discriminate neuropathy from control.

CONCLUSIONS

Dynamic contrast-enhanced perfusion is a feasible technique to assess K trans and NBV in peripheral nerves and may be used in future investigations on peripheral neuropathies.